[1]
Rani, G.F. et al. 2026. Impact of HbF inducers use on anti-cardiolipin and anti-beta2-glycoprotein I antibody levels in beta-thalassemia patients: a pilot study. KHYBER MEDICAL UNIVERSITY JOURNAL. 18, 1 (Mar. 2026), 78–84. DOI:https://doi.org/10.35845/kmuj.2026.24051.